252 related articles for article (PubMed ID: 17137605)
1. Microarray analysis of gene expression profile in the corpus cavernosum of hypercholesterolemic rats after chronic treatment with PDE5 inhibitor.
Jung HG; Shin JH; Kim KW; Yu JY; Kang KK; Ahn BO; Kwon JW; Yoo M
Life Sci; 2007 Jan; 80(7):699-708. PubMed ID: 17137605
[TBL] [Abstract][Full Text] [Related]
2. The effect of DA-8159, a novel PDE5 inhibitor, on erectile function in the rat model of hypercholesterolemic erectile dysfunction.
Kang KK; Yu JY; Yoo M; Kwon JW
Int J Impot Res; 2005; 17(5):409-16. PubMed ID: 15920460
[TBL] [Abstract][Full Text] [Related]
3. cDNA microarray analysis of differentially expressed genes in penile tissue after treatment with tadalafil.
Andrade E; Andrade PM; Borra RC; Claro J; Srougi M
BJU Int; 2008 Feb; 101(4):508-12. PubMed ID: 18005212
[TBL] [Abstract][Full Text] [Related]
4. The effect of PDE5 inhibition on the erectile function in streptozotocin-induced diabetic rats.
Ahn GJ; Sohn YS; Kang KK; Ahn BO; Kwon JW; Kang SK; Lee BC; Hwang WS
Int J Impot Res; 2005; 17(2):134-41. PubMed ID: 15578039
[TBL] [Abstract][Full Text] [Related]
5. Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum.
Zhang XH; Morelli A; Luconi M; Vignozzi L; Filippi S; Marini M; Vannelli GB; Mancina R; Forti G; Maggi M
Eur Urol; 2005 Mar; 47(3):409-16; discussion 416. PubMed ID: 15716209
[TBL] [Abstract][Full Text] [Related]
6. [Effect of berberine on the mRNA expression of phosphodiesterase type 5 (PDE5) in rat corpus cavernosum].
Tan Y; Tang Q; Hu B; Xiang J
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):890-3. PubMed ID: 15638014
[TBL] [Abstract][Full Text] [Related]
7. Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences.
Greco EA; Spera G; Aversa A
Eur Urol; 2006 Nov; 50(5):940-7. PubMed ID: 16979814
[TBL] [Abstract][Full Text] [Related]
8. Altered gene expression in rat mesenteric tissue following in vivo exposure to a phosphodiesterase 4 inhibitor.
Daguès N; Pawlowski V; Guigon G; Ledieu D; Sobry C; Hanton G; Freslon JL; Chevalier S
Toxicol Appl Pharmacol; 2007 Jan; 218(1):52-63. PubMed ID: 17157341
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy and erectile dysfunction: the current status.
Lau DH; Kommu SS; Siddiqui EJ; Thompson CS; Morgan RJ; Mikhailidis DP; Mumtaz FH
Asian J Androl; 2007 Jan; 9(1):8-15. PubMed ID: 16888683
[TBL] [Abstract][Full Text] [Related]
10. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat.
Ferrini MG; Kovanecz I; Sanchez S; Vernet D; Davila HH; Rajfer J; Gonzalez-Cadavid NF
Biol Reprod; 2007 May; 76(5):915-23. PubMed ID: 17287493
[TBL] [Abstract][Full Text] [Related]
11. [The effects of antisenes oligodeoxynucleotide on the cyclic nucleotide monophosphates in smooth muscle cells of human corpus cavernosum].
Bai WJ; Hou SK; Wang XF; Yan Z; He PY; Deng QP; Hu XP; Guan KP
Zhonghua Nan Ke Xue; 2002; 8(2):88-91. PubMed ID: 12479016
[TBL] [Abstract][Full Text] [Related]
12. Changes in the hepatic gene expression profile in a rat model of chronic ethanol treatment.
Park SH; Choi MS; Park T
Food Chem Toxicol; 2008 Apr; 46(4):1378-88. PubMed ID: 17920746
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase type 5 inhibithors in older males.
Frajese GV; Pozzi F
J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):112-5. PubMed ID: 16760638
[TBL] [Abstract][Full Text] [Related]
14. New achievement and novel therapeutic applications of PDE5 inhibithors in older males.
Frajese GV; Pozzi F
J Endocrinol Invest; 2005; 28(3 Suppl):45-50. PubMed ID: 16042360
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of an arteriogenic impotence model.
Lin CS; Ho HC; Gholami S; Chen KC; Jad A; Lue TF
Biochem Biophys Res Commun; 2001 Jul; 285(2):565-9. PubMed ID: 11444882
[TBL] [Abstract][Full Text] [Related]
16. Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction.
Salem EA; Kendirci M; Hellstrom WJ
Curr Opin Investig Drugs; 2006 Jul; 7(7):661-9. PubMed ID: 16869121
[TBL] [Abstract][Full Text] [Related]
17. Combined therapeutic effect of udenafil and adipose-derived stem cell (ADSC)/brain-derived neurotrophic factor (BDNF)-membrane system in a rat model of cavernous nerve injury.
Jeong HH; Piao S; Ha JN; Kim IG; Oh SH; Lee JH; Cho HJ; Hong SH; Kim SW; Lee JY
Urology; 2013 May; 81(5):1108.e7-14. PubMed ID: 23522997
[TBL] [Abstract][Full Text] [Related]
18. Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction.
Bi Y; Stoy P; Adam L; He B; Krupinski J; Normandin D; Pongrac R; Seliger L; Watson A; Macor JE
Bioorg Med Chem Lett; 2004 Mar; 14(6):1577-80. PubMed ID: 15006407
[TBL] [Abstract][Full Text] [Related]
19. Improving erectile function by silencing phosphodiesterase-5.
Lin G; Hayashi N; Carrion R; Chang LJ; Lue TF; Lin CS
J Urol; 2005 Sep; 174(3):1142-8. PubMed ID: 16094082
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.
Nagendran J; Archer SL; Soliman D; Gurtu V; Moudgil R; Haromy A; St Aubin C; Webster L; Rebeyka IM; Ross DB; Light PE; Dyck JR; Michelakis ED
Circulation; 2007 Jul; 116(3):238-48. PubMed ID: 17606845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
